201 related articles for article (PubMed ID: 38733184)
1. [Drug research and development and unmet needs for advanced-stage hepatocellular carcinoma].
Zhou HB; Hu HP
Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):306-311. PubMed ID: 38733184
[TBL] [Abstract][Full Text] [Related]
2. Combination treatment including targeted therapy for advanced hepatocellular carcinoma.
Lin J; Wu L; Bai X; Xie Y; Wang A; Zhang H; Yang X; Wan X; Lu X; Sang X; Zhao H
Oncotarget; 2016 Oct; 7(43):71036-71051. PubMed ID: 27626176
[TBL] [Abstract][Full Text] [Related]
3. Therapeutics for advanced hepatocellular carcinoma: Recent advances, current dilemma, and future directions.
Zhu J; Yin T; Xu Y; Lu XJ
J Cell Physiol; 2019 Aug; 234(8):12122-12132. PubMed ID: 30644100
[TBL] [Abstract][Full Text] [Related]
4. Potentiality of immunotherapy against hepatocellular carcinoma.
Tsuchiya N; Sawada Y; Endo I; Uemura Y; Nakatsura T
World J Gastroenterol; 2015 Sep; 21(36):10314-26. PubMed ID: 26420958
[TBL] [Abstract][Full Text] [Related]
5. Evolution of systemic treatment for advanced hepatocellular carcinoma.
Wu TC; Shen YC; Cheng AL
Kaohsiung J Med Sci; 2021 Aug; 37(8):643-653. PubMed ID: 34213069
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy for hepatocellular carcinoma: current situation and prospect.
Wang Z; Zhang G; Wu J; Jia M
Drug Discov Ther; 2013 Aug; 7(4):137-43. PubMed ID: 24071575
[TBL] [Abstract][Full Text] [Related]
7. "Hepatocellular carcinoma: A life-threatening disease".
Chacko S; Samanta S
Biomed Pharmacother; 2016 Dec; 84():1679-1688. PubMed ID: 27823920
[TBL] [Abstract][Full Text] [Related]
8. [Clinical advances in targeted therapy and immunotherapy for hepatocellular carcinoma].
Zhang DZ; Niu JQ
Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):834-837. PubMed ID: 31941237
[TBL] [Abstract][Full Text] [Related]
9. Systemic treatment of advanced hepatocellular cancer: new hope on the horizon.
Chang Lee R; Tebbutt N
Expert Rev Anticancer Ther; 2019 Apr; 19(4):343-353. PubMed ID: 30793991
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma: systemic therapies and future perspectives.
Mikhail S; Cosgrove D; Zeidan A
Expert Rev Anticancer Ther; 2014 Oct; 14(10):1205-18. PubMed ID: 25199765
[TBL] [Abstract][Full Text] [Related]
11. Systemic treatment for hepatocellular carcinoma.
Ján T; Dáša S; Igor A; Jana V
Klin Onkol; 2020; 33(5):356-361. PubMed ID: 33108880
[TBL] [Abstract][Full Text] [Related]
12. Advances in non-surgical management of primary liver cancer.
Chen X; Liu HP; Li M; Qiao L
World J Gastroenterol; 2014 Nov; 20(44):16630-8. PubMed ID: 25469032
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of the advanced HCC: A second revolution by using immunotherapy].
Fartoux L; Rosmorduc O
Biol Aujourdhui; 2018; 212(3-4):85-87. PubMed ID: 30973137
[TBL] [Abstract][Full Text] [Related]
14. Emerging drugs for the treatment of hepatocellular carcinoma.
Ayoub WS; Jones PD; Yang JD; Martin P
Expert Opin Emerg Drugs; 2022 Jun; 27(2):141-149. PubMed ID: 35642526
[TBL] [Abstract][Full Text] [Related]
15. Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment.
Yegin EG; Oymaci E; Karatay E; Coker A
Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):234-56. PubMed ID: 27298100
[TBL] [Abstract][Full Text] [Related]
16. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?
Obeid JM; Kunk PR; Zaydfudim VM; Bullock TN; Slingluff CL; Rahma OE
Cancer Immunol Immunother; 2018 Feb; 67(2):161-174. PubMed ID: 29052780
[TBL] [Abstract][Full Text] [Related]
18. Updated treatment approach to hepatocellular carcinoma.
Llovet JM
J Gastroenterol; 2005 Mar; 40(3):225-35. PubMed ID: 15830281
[TBL] [Abstract][Full Text] [Related]
19. Systemic therapies in hepatocellular carcinoma: present and future.
Bertino G; Di Carlo I; Ardiri A; Calvagno GS; Demma S; Malaguarnera G; Bertino N; Malaguarnera M; Toro A; Malaguarnera M
Future Oncol; 2013 Oct; 9(10):1533-48. PubMed ID: 24106903
[TBL] [Abstract][Full Text] [Related]
20. Bibliometric study of immunotherapy for hepatocellular carcinoma.
Li Z; Zhang Y; Zhang B; Guo R; He M; Liu ZL; Yang L; Wang H
Front Immunol; 2023; 14():1210802. PubMed ID: 37600802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
